Ítem
Acceso Abierto

Variability in the international normalised ratio (INR) in patients with antiphospholipid syndrome and positive lupus anticoagulant: Should the INR targets be higher?

Mostrar el registro sencillo de la publicación
dc.creatorBaquero-Salamanca, Marielenaspa
dc.creatorTéllez-Arévalo, Angélica Maríaspa
dc.creatorCalderón Ospina, Carlos Alberto
dc.date.accessioned2020-05-26T00:03:25Z
dc.date.available2020-05-26T00:03:25Z
dc.date.created2015spa
dc.description.abstractWe present the case of a 34-year-old woman with a history of antiphospholipid syndrome with triple positivity for antiphospholipid antibodies, who had multiple thrombotic events, predominantly pulmonary embolic events, despite treatment with enoxaparin. She is currently on warfarin, with which she has been adequately controlled most of the time, presenting with only one haemorrhagic event consisting of haematuria and prolonged international normalised ratio (INR) without bleeding. This kind of patient represents a challenge for clinicians, particularly due to INR therapeutic targets, which should be higher than recommended in other patients due to the lupus anticoagulant positivity.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1136/bcr-2014-209013
dc.identifier.issn1757790X
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/23590
dc.language.isoengspa
dc.publisherBMJ Publishing Groupspa
dc.relation.citationTitleBMJ Case Reports
dc.relation.citationVolumeVol. 2015
dc.relation.ispartofBMJ Case Reports, ISSN:1757790X, Vol.2015,(2015)spa
dc.relation.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84929484953&doi=10.1136%2fbcr-2014-209013&partnerID=40&md5=8593d65f5bdc2f7feb2656ace667dd9cspa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)spa
dc.source.instnameinstname:Universidad del Rosariospa
dc.source.reponamereponame:Repositorio Institucional EdocURspa
dc.subject.keywordEnoxaparinspa
dc.subject.keywordLupus anticoagulantspa
dc.subject.keywordPhospholipid antibodyspa
dc.subject.keywordProthrombin complexspa
dc.subject.keywordRivaroxabanspa
dc.subject.keywordWarfarinspa
dc.subject.keywordAnticoagulant agentspa
dc.subject.keywordEnoxaparinspa
dc.subject.keywordLupus anticoagulantspa
dc.subject.keywordWarfarinspa
dc.subject.keywordAdultspa
dc.subject.keywordAnemiaspa
dc.subject.keywordAntiphospholipid syndromespa
dc.subject.keywordArticlespa
dc.subject.keywordBleedingspa
dc.subject.keywordCase reportspa
dc.subject.keywordDeep vein thrombosisspa
dc.subject.keywordDrug treatment failurespa
dc.subject.keywordEndarterectomyspa
dc.subject.keywordErythrocyte transfusionspa
dc.subject.keywordFemalespa
dc.subject.keywordFood drug interactionspa
dc.subject.keywordHematuriaspa
dc.subject.keywordHumanspa
dc.subject.keywordInternational normalized ratiospa
dc.subject.keywordLaboratory testspa
dc.subject.keywordLung embolismspa
dc.subject.keywordOxygen therapyspa
dc.subject.keywordPatient compliancespa
dc.subject.keywordPriority journalspa
dc.subject.keywordPulmonary hypertensionspa
dc.subject.keywordThrombosisspa
dc.subject.keywordTreatment durationspa
dc.subject.keywordUpper gastrointestinal bleedingspa
dc.subject.keywordAntiphospholipid syndromespa
dc.subject.keywordBloodspa
dc.subject.keywordChemically inducedspa
dc.subject.keywordComplicationspa
dc.subject.keywordHematuriaspa
dc.subject.keywordHemorrhagespa
dc.subject.keywordInternational normalized ratiospa
dc.subject.keywordPulmonary embolismspa
dc.subject.keywordStandardsspa
dc.subject.keywordThrombosisspa
dc.subject.keywordTreatment outcomespa
dc.subject.keywordAdultspa
dc.subject.keywordAnticoagulantsspa
dc.subject.keywordAntiphospholipid syndromespa
dc.subject.keywordEnoxaparinspa
dc.subject.keywordFemalespa
dc.subject.keywordHematuriaspa
dc.subject.keywordHemorrhagespa
dc.subject.keywordHumansspa
dc.subject.keywordInternational normalized ratiospa
dc.subject.keywordLupus coagulation inhibitorspa
dc.subject.keywordPulmonary embolismspa
dc.subject.keywordThrombosisspa
dc.subject.keywordTreatment outcomespa
dc.subject.keywordWarfarinspa
dc.titleVariability in the international normalised ratio (INR) in patients with antiphospholipid syndrome and positive lupus anticoagulant: Should the INR targets be higher?spa
dc.typearticleeng
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.type.spaArtículospa
Archivos
Bloque original
Mostrando1 - 1 de 1
Miniatura
Nombre:
86440286.pdf
Tamaño:
222.42 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar
Colecciones
Artículos